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Introduction  
Prolonged febrile seizures (FS) and status epilepticus are the most frequent 
neurological emergencies in children. Subjects with Dravet syndrome and genetic 
epilepsy with febrile seizures plus (GEFS+), which are caused by SCN1A mutations, 
often suffer from prolonged febrile seizures (Dravet et al., 2005; Scheffer & Berkovic, 
1997). Early termination of prolonged seizures before arriving at the emergency 
department is associated with better patient outcomes. Therefore, it is important to 
establish a new therapy that is fast-acting, safe, and consistently achievable for 
paramedics. 
  
Inhalation of 5% carbon dioxide (CO2) strongly suppressed experimental FS in rats 
(Schuchmann et al., 2006). Thus, we investigated the efficacy of inhalation of a mixed 
gas containing 5% or 10% CO2 to treat FSs using hyperthermia-induced seizure 
susceptible (HISS) rats that harbored an Scn1a missense mutation (Mashimo et al., 
2010). 
 
  
  
Materials and Methods  
Animals  
We used male HISS rats with a homozygous N1417H-Scn1a mutation 
(F344/NSlc-Scn1aKyo811) (National Bio Resource Project for the Rat in Japan, Kyoto 
University, Kyoto, Japan) (Mashimo et al., 2008) and male wild-type (WT) littermates. 
The N1417H-Scn1a mutation produced a hyperpolarizing shift in voltage-dependent 
inactivation that results in reduced excitability of the hippocampal GABAergic 
interneurons in HISS rats. The rats were maintained in standard laboratory conditions 
with a 12-h light/dark cycle, and food and water were provided ad libitum. All 
experiments were performed in accordance with protocols approved by the Institutional 
Animal Care and Use Committee of Okayama University. 
 
 
Experimental conditions 
Induction of HIS and Electroencephalogram (EEG) recordings: 
The methods used for induction of HIS and EEG analysis have been described 
previously (Hayashi et al., 2011). Briefly, at 4 weeks of age, stainless-steel screw 
electrodes were placed on the bilateral frontal cortex (AP, +0.5 mm; ML, ±3.0 mm from 
bregma) and the bilateral occipital cortex (AP, −7.0 mm; ML, ±3.0 mm from bregma) 
for recordings and in the posterior end of the skull as a reference electrode. After a 
1-week recovery period, HISs were evoked by hot water baths at 45°C. The rats were 
kept in water for a maximum of 5 min, or until a seizure occurred. The duration of the 
seizures was measured using EEG (Neurofax EEG-1200, Nihon Koden, Japan). 
 
Inhalation of 5% CO2 or 10% CO2 
Immediately after the induction of HISs, a rat was placed into a multi-gas incubator 
(MCO-5M-PJ, Panasonic Corporation, Osaka, Japan) at 28°C for 3 min. The chamber 
was filled with air or mixed gas, which was composed of 5% CO2, 20% O2, and 75% N2, 
or 10% CO2, 20% O2, and 70% N2.  
 
Blood gas analysis 
One hundred microliters of peripheral blood was collected from a tail vein. The blood 
gas was analyzed to measure the pH, partial pressure of CO2 (pCO2), partial pressure of 
oxygen (pO2), and bicarbonate (HCO3−) using a blood gas analyzer (i-STAT Blood gas 
analyzer, Fuso Pharmaceutical Industries, Ltd, Osaka, Japan). To determine any changes 
in the biological parameters at the time of HISs, the blood gas analysis was performed 
under normal conditions and immediately after HIS occurred. For the WT rats, the 
blood gas was measured at the end of a 5-min hot water bath because they did not 
experience HIS. To evaluate the efficacy of inhalation of 5% CO2 or 10% CO2 for 
treating HIS, the blood gas was measured after placing the Scn1a mutant rat in a 
chamber filled with air or mixed gas that contained 5% CO2 or 10% CO2 for 3 min. 
 
Statistical analysis 
The data are presented as mean ± SEM. Significant differences were tested using the 
unpaired t-test to compare two groups. The association between the CO2 concentration 
and the anticonvulsant effect was evaluated using a one-way repeated measures ANOVA 
followed by a post hoc test (Fisher’s PLSD). Statistical differences were accepted if p 
value was < 0.05. 
 
Results 
 At 5 weeks of age, HISs did not occur in the WT rats (n = 19), whereas all of the 
Scn1a mutant rats (n = 19) experienced HISs within 5 min (Figure 1A, 1B). The rectal 
temperature at the onset of HISs in Scn1a mutant rats was significantly lower than that 
in the WT rats at the end of the 5-min hot water bath (Figure 1C). A representative EEG 
in the WT demonstrated no epileptic events during hot water bathing, whereas HISs 
(tonic posturing and head nodding with brief twitching movements followed by 
repetitive myoclonic jerks) were accompanied by diffuse high-voltage spikes and sharp 
waves in the EEG of the Scn1a mutant rats (Figure 1D). The blood gas analysis 
demonstrated that respiratory alkalosis with a reduction of HCO3- levels was induced in 
both WT and Scn1a mutant rats because of hot water bathing (Figure 1E–H). The 
duration of hot water bathing was shorter for the Scn1a mutant rats than that in the WT 
rats; therefore, a significantly milder induction of respiratory alkalosis was observed in 
the Scn1a mutant rats than in the WT rats (Figure 1E and 1F). 
 We examined the anticonvulsant effects of inhalation of 5% CO2 (n = 8) and 10% CO2 
(n = 12). Figures 2A, 2B, and 2C are representative EEGs during treatment with air, 5% 
CO2, and 10% CO2, respectively. Inhalation of 10% CO2 shortened the duration of 
repetitive myoclonic jerks. Video data 1 and 2 are representative simultaneous 
video-EEG recordings during treatment with air and 10% CO2, respectively. Inhalation 
of 10% CO2 markedly shortens the duration of HIS from 62.6 ± 12.1 s to 15.5 ± 1.0 s, 
whereas no significant anticonvulsant effect on HISs with 5% CO2 (48.4 ± 15.2 s) was 
observed (Figure 2D). Blood gas analysis demonstrated that inhalation of 5% or 10% 
CO2 resulted in a significant lowering of the pH (Figure 2E), a significant elevation of 
the pCO2 level (Figure 2F), and an elevation of the pO2 level (Figure 2G) compared to 
air treatment. However, the pH level of the 5% CO2 treatment was almost the same as 
that at physiological level at room temperature. 
 After the suppression of HISs with the inhalation of 5% or 10% CO2, the rats moved 
around normally, and their EEGs exhibited normal activity. Acidosis seemed to have no 
effect on the rats, except for the anticonvulsant effect. 
 
 
Discussion 
In general, experimental FS are difficult to evoke in rats after 3 weeks of age, 
therefore they were tested on postnatal days P8–P11. In a widely-used model using a 
hair dryer, HISs are caused by respiratory alkalosis following hyperventilation and loss 
of CO2 in rat pups on postnatal days P8–P11 (Schuchmann et al., 2006). The expression 
of neuronal sodium channel Nav1.1, which is encoded by Scn1a, becomes prominent in 
rats at approximately 5 weeks of age (Mashimo et al., 2010). FS associated with SCN1A 
mutations in humans persist beyond 6 years of age. On the basis of these factors, we 
used 5-week-old rats that were older than the usual model rats. Hot water bathing 
induced a significant reduction in the pCO2 level, an elevation of the pO2 level, and 
alkalosis. Although a successful induction of respiratory alkalosis in the WT and Scn1a 
mutant rats at 5 weeks of age was observed, the WT rats did not experience HISs, 
whereas 100% of the Scn1a mutant rats experienced HISs. Differences of HIS 
susceptibility in the Scn1a mutant rats may have affected the age-dependent excitability 
of the brain, which reacts to alkalosis. 
Inhalation of 10% CO2 produced fast-acting and strong suppression of HISs in the 
Scn1a mutant rats at 5 weeks of age, whereas 5% CO2 demonstrated no significant 
effects in them. In our experimental protocol, the delay during the transfer of the rat 
from the bath to the chamber was about 7–9 s; therefore, the estimated period when the 
HISs stopped after the inhalation of 10% CO2 was less than 10 s. On the basis of the 
blood gas data after the end of HISs, respiratory acidosis because of the inhalation of 
10% CO2 might rapidly abolish HISs. However, the pCO2 level after the 10% CO2 
treatment was still lower than that of the physiological pCO2 level. This data indicates 
that partial recovery of pCO2 may be sufficient to suppress HISs even though it does not 
reach the physiological level. The anticonvulsant action of CO2 was demonstrated in 
epileptic humans over 80 years ago (Lennox, 1928). Recent studies have demonstrated 
that 5% CO2 strongly suppressed experimental FS in rats on postnatal days P10–11, 
myoclonic epilepsy in a rat model, and intractable partial epilepsy in human subjects 
(Schuchmann et al., 2006; Tolner et al., 2010). In this study, the differing effects of 
inhalation of 5% CO2 may have been due to the insufficient induction of acidosis, the 
differences in animal models, age, genetic background, or the experimental procedures. 
The molecular mechanisms that suppress seizures with the inhalation of CO2 are 
largely unknown. The dilation of cerebral vessels with CO2 or changes in the 
biophysical properties of Scn1a mutant channels against acidosis might contribute to the 
anticonvulsant action. An SCN1A mutation linked to the Dravet syndrome led to a 
significant reduction in the persistent sodium current with a decrease in intracellular pH 
(Rhodes et al., 2004).  
The effects of antiepileptic drugs on HISs in Scn1a mutant rats reflect the results of 
a study conducted in human subjects with Dravet syndrome and GEFS+ (Hayashi et al., 
2011). In our previous study, inhalation of 10% CO2 exhibited approximately the same 
effect as diazepam on the termination of HISs. To improve the outcomes for patients 
with prolonged seizures, paramedics have begun to administer intramuscular or 
intravenous benzoziazepines to patients before arriving at the emergency departments 
(Warden et al., 2006; Silbergleit et al., 2012). Subjects with SCN1A mutation-related 
epileptic syndromes often have prolonged febrile seizures. Inhalation of a mixed gas 
containing CO2 does not need specific medical training; therefore, not only paramedics 
but also the patients’ families can administer it. However, safety issues should be 
addressed before the clinical application of inhalation of CO2 in epileptic patients. It is 
notable that 10% CO2 rapidly terminates HISs in Scn1a mutant rats, which may lead to 
the development of a new therapy to treat SCN1A mutation-related epileptic syndromes. 
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Figure legends 
Figure 1. Induction of HIS and changes in the blood gas parameters. 
A: WT rats (n = 19) did not experience HISs, whereas 100% of the homozygous Scn1a 
mutants (n = 19) experienced HISs B: Latency occurred before HIS. Hot water bathing 
was stopped after 300 s in the WT rats because HISs were not evoked. The Scn1a 
mutant rats experienced HIS at 224.1 ± 11.3 s C: The rectal temperature in the WT rats 
at the end of the hot water bath and at the induction of HISs in the Scn1a mutant rats D: 
Representative EEGs in the WT rats during hot water bathing and ictal EEG in the 
Scn1a mutant rats E–H: Blood gas analysis of the peripheral blood taken from a tail 
vein under normal conditions and immediately after 3 min of hot water bathing in WT 
(n = 12) and when HISs occurred in the Scn1a mutant rats (n = 12) E: pH F: pCO2 G: 
pO2 H: HCO3− **p < 0.001, *p < 0.01 
 
Figure 2. The anticonvulsant effect of inhalation of 5% CO2 or 10% CO2 Immediately 
after the induction of HIS, a rat was placed in a multi-gas incubator filled with air (n = 
12), 5% CO2 (n = 8), or 10% CO2 (n = 12) for 3 min. The blood gas parameters were 
then analyzed. Representative EEGs when the rat was placed in a chamber filled with 
air (A), mixed gas containing 5% CO2, 20% O2, and 75% N2 (B), or mixed gas 
containing 10% CO2, 20% O2, and 70% N2 (C) The duration of the HISs in mixed gas 
containing 10% CO2 was significantly shorter than that in air (10% CO2 vs. air, **p = 
3.7 x 10-5) (D) Blood gas analysis of pH (5% CO2 vs. air, *p = 0.0055; 10% CO2 vs. 
air, **p = 9.7 x 10-7 (E), pCO2 (5% CO2 vs. air, *p = 0.014; 10% CO2 vs. air, **p 
= 2.2 x 10-5) (F),  pO2  (5% CO2 vs. air, *p = 0.045; 10% CO2 vs. air, **p = 1.2 
x 10-8) (G) , and HCO3− (H).  **p < 0.001, *p < 0.05  
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